During the past decade, MultiCare Deaconess Cancer and Blood Specialty Center - Valley conducted 84 clinical trials. In the 10-year time frame, 84 clinical trials started and 43 clinical trials were completed, i.e. on average, 51.2% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 40 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MultiCare Deaconess Cancer and Blood Specialty Center - Valley" #1 sponsor was "National Cancer Institute (NCI)" with 46 trials, followed by "Alliance for Clinical Trials in Oncology" with 23 trials sponsored, "SWOG Cancer Research Network" with 21 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored and "Gynecologic Oncology Group" with 9 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MultiCare Deaconess Cancer and Blood Specialty Center - Valley" #1 collaborator was "National Cancer Institute (NCI)" with 62 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 3 trials as a collaborator and "Genentech, Inc." with 2 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "MultiCare Deaconess Cancer and Blood Specialty Center - Valley" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Recurrent Breast Carcinoma" (5 trials), "Stage IIIA Breast Cancer" (5 trials) and "Invasive Breast Carcinoma" (4 trials). Many other conditions were trialed in "MultiCare Deaconess Cancer and Blood Specialty Center - Valley" in a lesser frequency.

Most popular intervention types in "MultiCare Deaconess Cancer and Blood Specialty Center - Valley" are "Drug" (85 trials), "Other" (72 trials), "Biological" (42 trials), "Procedure" (31 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (40 trials), "Quality-of-Life Assessment" (27 trials), "Computed Tomography" (17 trials), "Biospecimen Collection" (16 trials) and "Questionnaire Administration" (16 trials). Other intervention names were less common.

The vast majority of trials in "MultiCare Deaconess Cancer and Blood Specialty Center - Valley" are 87 trials for "All" genders, 19 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "MultiCare Deaconess Cancer and Blood Specialty Center - Valley". undefined are not yet recruiting, 19 are recruiting, 65 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in MultiCare Deaconess Cancer and Blood Specialty Center - Valley, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in MultiCare Deaconess Cancer and Blood Specialty Center - Valley, 5 "Phase 1" clinical trials were conducted, 53 "Phase 2" clinical trials and 58 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".